R Squared’s Kyntra Bio KYNB Stock Holding History

R Squared’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-578	Closed	-$4.47K	–	499
2025 Q1	$4.47K	Buy	578 +207	+56%	+$2.48K	﹤0.01%	288
2024 Q4	$4.91K	Buy	+371	New	+$3.45K	﹤0.01%	1314

Other funds holding KYNB

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

R Squared's KYNB Position: Q2 2025 in Review

R Squared sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 578 shares — an estimated $4.47K sold.

R Squared first reported a position in KYNB in Q4 2024 and held it in 2 quarters. The position peaked at $4.91K in Q4 2024. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

R Squared reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
R Squared sold 578 Kyntra Bio shares in Q2 2025, an estimated $4.47K.
R Squared first reported a position in Kyntra Bio in Q4 2024 and held it in 2 quarters.
R Squared's Kyntra Bio position peaked at $4.91K in Q4 2024.
30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on R Squared's 13F filing for Q2 2025, filed 31 Jul 2025.